Verdezyne Closes Funding Round

Carlsbad, CA-based Verdezyne, which has been developing industrial biotechnology processes for making adipic acid and other sustainable chemicals and fuels, says today it has closed a new funding round. While the amount of funding was not disclosed, Verdezyne says two of the investors, BP Alternative Energy Ventures and DSM Venturing B.V., joined in the round with existing investors OVP Venture Partners and Monitor Ventures. Verdezyne CEO Bill Radany also told VentureWire the company has agreed to work with BP in its efforts to develop cellulosic ethanol, technology that BP acquired from Verenium.

Bruce V. Bigelow was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here. Follow @bvbigelow

Trending on Xconomy